Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Heart failure in 1991.

G S Francis1

  • 1Department of Medicine, University of Minnesota, Minneapolis.

Cardiology
|January 1, 1991
PubMed
Summary
This summary is machine-generated.

Congestive heart failure is a major health issue, especially for older adults. Research is refining treatments like angiotensin-converting enzyme inhibitors and exploring early interventions to prevent advanced heart failure.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The high-risk patient with heart failure with reduced ejection fraction: treatment options and challenges.

Clinical pharmacology and therapeutics·2013
Same author

Cardiac troponins and chronic kidney disease.

Kidney international·2006
Same author

Plasma BNP concentration predicted the presence of heart failure.

Evidence-based cardiovascular medicine·2005
Same author

Brain natriuretic peptide concentration was effective for screening for LV systolic dysfunction.

Evidence-based cardiovascular medicine·2005
Same author

Pregnancy outcomes during treatment with interferon beta-1a in patients with multiple sclerosis.

Neurology·2005
Same author

Randomized study of once-weekly interferon beta-1la therapy in relapsing multiple sclerosis: three-year data from the OWIMS study.

Multiple sclerosis (Houndmills, Basingstoke, England)·2005
Same journal

Aortic Valve Sclerosis: More Than an Incidental Echocardiographic Finding.

Cardiology·2026
Same journal

Can resting segmental strain identify obstructive coronary artery disease in chronic coronary syndrome patients referred to CABG?

Cardiology·2026
Same journal

Mortality Impact of Stroke and Major Bleeding Across the Ejection Fraction Spectrum in Patients Hospitalized for Acute Heart Failure With Prevalent Atrial Fibrillation.

Cardiology·2026
Same journal

Impact of Inflammatory Disorders on Outcomes in Acute Heart Failure: A Nationwide Analysis.

Cardiology·2026
Same journal

Predictors and Clinical Impact of Tricuspid Regurgitation After Pericardiectomy for Constrictive Pericarditis.

Cardiology·2026
Same journal

Utilization of Guideline-Directed Medical Therapies and Transcatheter-Edge-to-Edge Repair in Patients with Significant Secondary Mitral Regurgitation.

Cardiology·2026
See all related articles

Area of Science:

  • Cardiology
  • Public Health
  • Pharmacology

Background:

  • Congestive heart failure (CHF) is a significant global public health concern.
  • It is the leading cause of hospitalization for individuals over 65 in the United States.
  • Recent clinical trials have informed current CHF treatment strategies.

Purpose of the Study:

  • To summarize current treatment strategies for chronic congestive heart failure.
  • To highlight the role of specific pharmacologic therapies.
  • To outline future research directions in understanding and preventing advanced CHF.

Main Methods:

  • Review of clinical trials and established treatment protocols for congestive heart failure.
  • Analysis of the efficacy of key pharmacologic agents.

Related Experiment Videos

  • Identification of emerging research areas.

    • Main Results:

    • Angiotensin-converting enzyme inhibitors are a key pharmacologic therapy for CHF.
    • Digitalis and diuretics remain widely utilized in CHF management.
    • Ongoing and planned clinical trials aim to further optimize treatment.

    Conclusions:

    • Current treatments for CHF are evolving based on clinical trial data.
    • Future research will focus on the pathophysiology of myocardial damage and preventative therapies.
    • Understanding disease progression is crucial for developing early interventions to prevent end-stage heart failure.